CDK2 and hepatocellular carcinoma: The kinase-independent nature of cyclin E in HCC progression was also highlighted by the finding that CRISPR/Cas9 CDK2 deletion and kinase dead forms of CDK2 were not sufficient to abolish cell growth [233].